Answers are grounded in this paper and cite their sources.
New triterpenoids were isolated from Dysoxylum cumingianum, demonstrating cytotoxicity against human breast adenocarcinoma and oral squamous cell carcinoma.
Two new 14,18-cycloapoeuphane triterpenoids, cumingianols G (1) and H (2), along with 12 known compounds, cumingianol C (3), cumingianol A (4), cumingianol D (5), 3,3-ethylenedioxy-5α-cycloart-24-en-23-one (6), 24,25(R,S)-24,25-epoxy-20(S)-hydroxydammar-3-one (7), (3β,7α)-stigmast-5-ene-3,7-diol (8), 7α-hydroxystigmasterol (9), 7β-hydroxysitosterol (10), 7β-hydroxystigmasterol (11), ethylcholest-5-en-3-hydroxy-7-one (12), coniferaldehyde (13) and 4-hydroxy-3,5-dimethoxy-benzaldehyde (14), have been isolated from Dysoxylum cumingianum collected in Taiwan. The structures of these metabolites were determined through mass spectrometry and 1D and 2D NMR analyses, combined with comparisons to reference data. The cytotoxic effects of these isolates were evaluated against human oral squamous cell carcinoma (SCC2095), human breast adenocarcinoma (MCF-7), and human gastric adenocarcinoma (SCM-1). Among them, compound 4 exhibited significant cytotoxicity against the SCC2095 and MCF-7 cell lines, with IC50 values of 6.3 μM and 6.1 μM, respectively.
No takes yet. Share an insight, caveat, or question.
Huynh et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: